E H Ulm
Impact in
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Protein Hydrolysis and Bioactive Peptides 9
- Retinoids in leukemia and cellular processes 8
- Chemical Synthesis and Analysis 7
- Oncology 8
- Co-authors
- Daniel H. Rich (2 shared papers)Eric T. Sun (1 shared paper)Michael A. Shirley (4 shared papers)Bruce I. LaMont (6 shared papers)Joshua Boger (7 shared papers)Martin Poe (6 shared papers)Burton M. Pogell (3 shared papers)Edward H. Blaine (4 shared papers)
- Journals
- Drug Metabolism and Disposition (9 papers)Journal of Medicinal Chemistry (7 papers)Biochemical and Biophysical Research Communications (3 papers)Cardiovascular Drug Reviews (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United States
In The Last Decade
E H Ulm
47 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Biochemistry 104
- Pharmacology 136
- Molecular Biology 1.0k
- Biochemistry 71
- Computational Theory and Mathematics 155
Countries citing papers authored by E H Ulm
This map shows the geographic impact of E H Ulm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E H Ulm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E H Ulm more than expected).
Fields of papers citing papers by E H Ulm
This network shows the impact of papers produced by E H Ulm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E H Ulm. The network helps show where E H Ulm may publish in the future.
Co-authors
The 25 scholars most cited alongside E H Ulm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 137 | |
| 2 | 1980 | 118 | |
| 3 | 1985 | 111 | |
| 4 | 2006 | 96 | |
| 5 | 2007 | 96 | |
| 6 | A Phase I study of LGD1069 in adults with advanced cancer. | 1999 | 88 |
| 7 | 1995 | 79 | |
| 8 | 1972 | 65 | |
| 9 | 1983 | 62 | |
| 10 | Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. | 1996 | 55 |
| 11 | 1975 | 51 | |
| 12 | 1993 | 47 | |
| 13 | 1973 | 44 | |
| 14 | 1990 | 43 | |
| 15 | 1982 | 42 | |
| 16 | 1984 | 41 | |
| 17 | Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes. | 1998 | 39 |
| 18 | 1975 | 37 | |
| 19 | 1984 | 31 | |
| 20 | 1985 | 28 |
About E H Ulm
E H Ulm is a scholar working on Molecular Biology, Oncology, Genetics, Pharmacology and Biochemistry, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein Hydrolysis and Bioactive Peptides (9 papers), Retinoids in leukemia and cellular processes (8 papers), Estrogen and related hormone effects (8 papers), Chemical Synthesis and Analysis (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Computational Drug Discovery Methods (5 papers). The work is most often cited by research in Biochemistry (104 citations), Pharmacology (136 citations), Molecular Biology (1.0k citations), Biochemistry (71 citations) and Computational Theory and Mathematics (155 citations). E H Ulm has collaborated with scholars based in United States. Frequent co-authors include Daniel H. Rich, Eric T. Sun, Michael A. Shirley, Bruce I. LaMont, Joshua Boger, Martin Poe, Burton M. Pogell, Edward H. Blaine, Terry W. Schorn and Linda S. Payne. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications, Cardiovascular Drug Reviews and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.